Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic acid in NASH (FLINT)
NCT01265498Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Mar 2011
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of obeticholic acid in Nonalcoholic steatohepatitis (NASH), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Mar 2011; status: completed.
02
Drugs
obeticholic acid
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01265498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265498.